Literature DB >> 20594225

Is it necessary to perform prophylactic cholecystectomy for asymptomatic subjects with gallbladder polyps and gallstones?

Sung Youn Choi1, Tae Sun Kim, Hong Joo Kim, Jung Ho Park, Dong Il Park, Yong Kyun Cho, Chong Il Sohn, Woo Kyu Jeon, Byung Ik Kim.   

Abstract

BACKGROUND AND AIMS: The purpose of the present study was to determine the clinical characteristics of subjects with gallbladder polyps and cholelithiasis compared with those with gallbladder polyps only.
METHODS: Between August 1999 and December 2005, 176 subjects with gallbladder polyps and cholelithiasis (study group) by transabdominal ultrasonography performed during a medical check-up at our institution were recruited and compared with a control group of 185 subjects who had gallbladder polyps only.
RESULTS: No significant difference in the mean interval change (delta) of polyp size during the follow-up period between the study and control groups (0.85 +/- 1.39 mm vs 0.84 +/- 1.58 mm, respectively, P = 0.927) was noted. A significantly higher proportion (9/176 [5.1%]) of examinees in the study group had attacks of acute cholecystitis compared with the control group (1/185 [0.5%], P < 0.01). By multivariate logistic regression analysis, gallbladder wall thickening on initial ultrasonography (odds ratio, 13.7; 95% confidence interval, 1.1-178.0; P = 0.046) and the interval increase in the size of the gallbladder polyps (odds ratio, 14.7; 95% confidence interval, 1.7-126.9; P = 0.014) were independent risk factors for cholecystectomy. No gallbladder cancer occurred during the follow-up period.
CONCLUSIONS: There was no significant difference in delta polyp size between the examinees with gallbladder polyps and cholelithiasis and those with gallbladder polyps only. Hence, a small proportion of subjects with gallbladder polyps and cholelithiasis, such as those with thickened gallbladder walls and an interval increase in the size of the gallbladder polyps are candidates for prophylactic cholecytectomy.

Entities:  

Mesh:

Year:  2010        PMID: 20594225     DOI: 10.1111/j.1440-1746.2010.06288.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  7 in total

1.  Is it necessary to perform prophylactic cholecystectomy for all symptomatic gallbladder polyps diagnosed with ultrasound?

Authors:  Mehmet Velidedeoğlu; Bülent Çitgez; Akif Enes Arıkan; Fadıl Ayan
Journal:  Turk J Surg       Date:  2016-03-04

2.  Polypoid lesions of the gallbladder: analysis of 1204 patients with long-term follow-up.

Authors:  Shu-Cheng Chou; Shih-Chin Chen; Yi-Ming Shyr; Shin-E Wang
Journal:  Surg Endosc       Date:  2016-12-30       Impact factor: 4.584

3.  Are there modifiable risk factors affecting the prevalence of gallbladder polyps or those 5 mm or larger? A retrospective cross-sectional study.

Authors:  Oh-Sung Kwon; Young-Kyu Kim
Journal:  Medicine (Baltimore)       Date:  2021-09-03       Impact factor: 1.817

4.  Management and diagnosis of gallbladder polyps: a systematic review.

Authors:  Benoy I Babu; Ashley R Dennison; Giuseppe Garcea
Journal:  Langenbecks Arch Surg       Date:  2015-04-25       Impact factor: 3.445

5.  Neoplastic polyps in gallbladder: a retrospective study to determine risk factors and treatment strategy for gallbladder polyps.

Authors:  Yongliang Sun; Zhiying Yang; Xu Lan; Haidong Tan
Journal:  Hepatobiliary Surg Nutr       Date:  2019-06       Impact factor: 7.293

6.  Diagnosis and management of gallbladder polyps.

Authors:  Ake Andrén-Sandberg
Journal:  N Am J Med Sci       Date:  2012-05

7.  Management and follow-up of gallbladder polyps : Joint guidelines between the European Society of Gastrointestinal and Abdominal Radiology (ESGAR), European Association for Endoscopic Surgery and other Interventional Techniques (EAES), International Society of Digestive Surgery - European Federation (EFISDS) and European Society of Gastrointestinal Endoscopy (ESGE).

Authors:  Rebecca Wiles; Ruedi F Thoeni; Sorin Traian Barbu; Yogesh K Vashist; Søren Rafael Rafaelsen; Catherine Dewhurst; Marianna Arvanitakis; Max Lahaye; Marek Soltes; Julie Perinel; Stuart Ashley Roberts
Journal:  Eur Radiol       Date:  2017-02-09       Impact factor: 5.315

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.